Financial Performance - The company reported a net loss of 132 million yuan for the fiscal year 2024, primarily due to significant credit impairment losses on accounts receivable and a decline in operating revenue, which did not sufficiently cover period expenses [2][4]. Future Growth Drivers - The company plans to enhance business expansion by deepening its focus on the mobile information security market, innovating technologies and products, and integrating external resources to explore new business opportunities [4]. - The company will also continue to develop its pharmaceutical business through its subsidiary, Hefei Tuorui Biotechnology Co., Ltd., which specializes in chemical drug research and development [4]. Industry Overview - The cybersecurity industry has seen a rebound in market growth, although it has not yet returned to previous high-growth levels. Performance varies among companies based on their specific market segments [5]. - The proliferation of new technologies, such as artificial intelligence, is expected to drive innovation in cybersecurity, while also introducing more complex attack methods [6]. Future Industry Outlook - The cybersecurity market has significant growth potential, supported by the government's increasing focus on digital infrastructure and cybersecurity policies. However, it also faces risks from external economic conditions, intensified market competition, and uncertainties in technology implementation [6]. Restructuring and Risk Management - The company is actively taking measures to improve its operational and financial conditions, aiming to enhance main business revenue and profitability to mitigate delisting risks. Strategies include optimizing management processes, controlling costs, and improving accounts receivable management [8].
*ST国华(000004) - 000004*ST国华投资者关系管理信息20250526